A new primate model for multiple sclerosis in the common marmoset

BA't Hart, M Van Meurs, HPM Brok, L Massacesi… - Immunology today, 2000 - cell.com
Experimental autoimmune encephalomyelitis (EAE) in outbred marmoset monkeys
(Callithrix jacchus) is a recently developed nonhuman primate model of multiple sclerosis …

[HTML][HTML] Epstein–Barr virus in multiple sclerosis: theory and emerging immunotherapies

A Bar-Or, MP Pender, R Khanna, L Steinman… - Trends in molecular …, 2020 - cell.com
New treatments for multiple sclerosis (MS) focused on B cells have created an atmosphere
of excitement in the MS community. B cells are now known to play a major role in disease …

CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis–Targeting T or B cells?

MC Agahozo, L Peferoen, D Baker, S Amor - Multiple sclerosis and related …, 2016 - Elsevier
MS is widely considered to be a T cell-mediated disease although T cell immunotherapy has
consistently failed, demonstrating distinct differences with experimental autoimmune …

Epstein-Barr virus and multiple sclerosis

JD Lünemann, C Münz - Current neurology and neuroscience reports, 2007 - Springer
Epstein-Barr virus (EBV) is one of the most common and successful human viruses, infecting
more than 90% of the world's adult population. Despite its strong tumorigenic potential, most …

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM

TV Lanz, RC Brewer, PP Ho, JS Moon, KM Jude… - Nature, 2022 - nature.com
Multiple sclerosis (MS) is a heterogenous autoimmune disease in which autoreactive
lymphocytes attack the myelin sheath of the central nervous system. B lymphocytes in the …

The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis

YS Kap, SA Jagessar, J Dunham, BA't Hart - Drug discovery today, 2016 - Elsevier
Highlights•We developed a valid preclinical model for chronic MS in marmosets.•The model
displays pathological aspects of progressive MS in cortical grey matter.•The model shows a …

EBNA1 inhibitors block proliferation of spontaneous lymphoblastoid cell lines from patients with multiple sclerosis and healthy controls

MCG Monaco, SS Soldan, C Su, A Clauze… - Neurology …, 2023 - AAN Enterprises
Background and Objectives Epstein-Barr virus (EBV) is a ubiquitous herpesvirus that
establishes lifelong latency in memory B cells and has been identified as a major risk factor …

Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism

OG Thomas, A Rickinson… - Clinical & Translational …, 2023 - Wiley Online Library
Abstract The link between Epstein–Barr virus (EBV) and multiple sclerosis (MS) has puzzled
researchers since it was first discovered over 40 years ago. Until that point, EBV was …

B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune encephalomyelitis

YS Kap, J Bauer, N Driel, WK Bleeker… - … of Neuropathology & …, 2011 - academic.oup.com
This study investigated the effect of CD20-positive B-cell depletion on central nervous
system (CNS) white and gray matter pathology in experimental autoimmune …

Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven …

B Serafini, B Rosicarelli, C Veroni, GA Mazzola… - Journal of …, 2019 - Am Soc Microbiol
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus strongly associated with multiple
sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS) …